Suma Krishnan, Chief Operating Officer at Krystal Biotech, Inc. (KRYS), sold 100,000 shares at $44.56 ($4.3M) on 2020-06-15, disclosed to the SEC on 2020-06-17.
Open-market sale of $4.3M KRYS by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.31 | 7,578 | $313K | 7.2% |
| 2 | $41.31 | 7,578 | $313K | 7.2% |
| 3 | $42.24 | 8,652 | $365K | 8.4% |
| 4 | $42.24 | 8,652 | $365K | 8.4% |
| 5 | $43.21 | 10,740 | $464K | 10.7% |
| 6 | $43.21 | 10,740 |
| $464K |
| 10.7% |
| 7 | $44.56 | 11,311 | $504K | 11.6% |
| 8 | $44.56 | 11,311 | $504K | 11.6% |
| 9 | $45.07 | 11,719 | $528K | 12.1% |
| 10 | $45.07 | 11,719 | $528K | 12.1% |
| Total | $43.50 avg | 100,000 | $4.3M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |